Vaniam Group
Rob Coleman is a seasoned medical professional currently serving as the Chief Medical Officer at Vaniam Group since May 2023. Previously, Rob held the position of Chief Scientific Officer at McKesson from March 2020 to May 2023. Prior to that role, Rob spent over 15 years at the University of Texas, M.D. Anderson Cancer Center, where Rob was a Professor and Deputy Chair. Rob's extensive experience in leadership and scientific roles underscores a strong commitment to advancing medical research and practice.
This person is not in any offices
Vaniam Group
1 followers
Vaniam Group offers consulting, scientific communication, expert engagement & insights-gathering services within the oncology field.